New contract, page-27

LOL , Rusty...that is Medimmune. This is Sanofi-REGN

Red...
Well Alirocumab is Ph 3 but lets wait to see what Choice 1 reveals. Dupilumab just came though very strong phase 2 studies. The others are Ph 1

If you want to talk near term I am hoping Secukinumab gets thrown into the UNS trolley. That would be a good near term drug to land. Much like Alirocumab.

That spreadsheet copy and paste are only the Sanofi drugs and there are 4 other particular pharma that I am watching to see which way they head. Some are nearer term in Ph 2. One of the ones that was very encouraging just got delayed due to lack of R&D funding and manufacturing capacity to produce clinical trial drug. Bugger.

So there are of course many more out there but I tend to only look at the ones I do because I am lazy and they are some of the easier programs to follow as multiple players in the same sand pit makes it easier vs a single pharma developing a drug